Insider Transactions in Q4 2024 at Arrowhead Pharmaceuticals, Inc. (ARWR)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2024
|
Adeoye Y Olukotun Director |
SELL
Open market or private sale
|
Direct |
2,850
-7.2%
|
$57,000
$20.0 P/Share
|
|
Dec 23
2024
|
Christopher Richard Anzalone Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,563
-0.33%
|
$238,697
$19.59 P/Share
|
|
Dec 18
2024
|
Lu Hongbo Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,733
+26.19%
|
$368,126
$22.99 P/Share
|
|
Dec 18
2024
|
Michael S Perry Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,733
+11.29%
|
$368,126
$22.99 P/Share
|
|
Dec 18
2024
|
Mauro Ferrari Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,733
+17.75%
|
$368,126
$22.99 P/Share
|
|
Dec 18
2024
|
William D. Waddill Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,733
+22.66%
|
$368,126
$22.99 P/Share
|
|
Dec 18
2024
|
Adeoye Y Olukotun Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,733
+29.71%
|
$368,126
$22.99 P/Share
|
|
Dec 18
2024
|
Victoria Vakiener Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,733
+30.6%
|
$368,126
$22.99 P/Share
|
|
Dec 18
2024
|
Christopher Richard Anzalone Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+2.57%
|
-
|
|
Dec 18
2024
|
Christopher Richard Anzalone Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,712
-0.24%
|
$560,952
$21.46 P/Share
|
|
Dec 17
2024
|
Douglas B Given Director |
SELL
Open market or private sale
|
Direct |
547
-0.44%
|
$12,034
$22.04 P/Share
|
|
Dec 17
2024
|
William D. Waddill Director |
SELL
Open market or private sale
|
Direct |
3,747
-8.49%
|
$82,434
$22.04 P/Share
|
|
Dec 16
2024
|
Victoria Vakiener Director |
SELL
Open market or private sale
|
Direct |
8,994
-29.78%
|
$188,874
$21.91 P/Share
|
|
Dec 16
2024
|
Douglas B Given Director |
SELL
Open market or private sale
|
Direct |
5,000
-3.85%
|
$105,000
$21.9 P/Share
|
|
Dec 16
2024
|
William D. Waddill Director |
SELL
Open market or private sale
|
Direct |
3,748
-7.83%
|
$78,708
$21.9 P/Share
|